Its easy to give yourself, using a small needle that you can inject into your belly, thigh, or upper arm
Our healthcare team is dedicated to working closely with each patient to assess their unique health needs and determine if Semaglutide GLP-1 is the right choice for them
It belongs to a novel class of agents known as triple agonists, targeting three incretin and metabolic receptors simultaneously: the glucagon-like peptide-1 (GLP-1) receptor, the glucose-dependent insulinotropic polypeptide (GIP) receptor, and the glucagon receptor
Moreover, we found that GLP1-RA significantly reduced the rate of major adverse limb events compared with SGLT2i, which was consistent with the conclusions in two retrospective cohort studies [40,41]
Yes, patients start losing weight even with the starting dose of 0.25 mg